Skip to main content
Log in

The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils

  • Allergy and Histamine
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

We investigated the effect of WEB 2086, a selective platelet-activating factor (PAF) receptor antagonist, on PAF-induced eosinophil chemotaxis and LTC4 production. WEB 2086 inhibited PAF-induced eosinophil chemotaxis in normals and asthmatics. To further determine if WEB 2086 is a selective PAF receptor antagonist, we examined the effect of WEB 2086 against formyl-methionyl-leucyl-phenylalanine (fMLP)-induced or eosinophil chemotactic factor of anaphylaxis (ECF-A)-induced eosinophil chemotaxis. WEB 2086 did not have a significant inhibition against fMLP or ECF-A-induced eosinophil chemotaxis. These results suggest that WEB 2086 is a selective and potent inhibitor of PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils, due to its antagonism of PAF-receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

PAF:

platelet activating factor

LTC4 :

leukotriene C4

fMLP:

formyl-methionyl-leucyl-phenylalanine

ECF-A:

eosinophil chemotactic factor of anaphylaxis

HBSS:

Hank's balanced salt solution

HPF:

high power field

References

  1. F. Snyder,Chemical and biochemical aspects of platelet activating factor: A novel class of acetylated ether-linked choline phospholipids. Med. Res. Rev.5, 107–140 (1985).

    PubMed  Google Scholar 

  2. C. P. Page, C. B. Archer, W. Paul and J. Morley,Pafacether: A mediator of inflammation and asthma. Trends Pharmacol. Sci.5, 239–241 (1984).

    Article  Google Scholar 

  3. R. N. Pinckard, L. M. McManus, M. Halonen, D. J. Hanahan,Immunopharmacology of acetyl glyceryl ether phosphorlcholine (AGEPC). InImmunopharmacology of the Lung. (Ed. H. H. Newball) Marcel-Dekker, New York, pp. 74–103 (1983).

    Google Scholar 

  4. B. B. Vargaftig, M. Chignard, J. Benveniste, J. Lefort and F. Wal,Background and present status of research on plateletactivating factor. Ann. N.Y. Acad. Sci.370, 119–137 (1981).

    PubMed  Google Scholar 

  5. H. Darius, D. J. Lefer, J. B. Smith and A. M. Lefer,Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis. Science232, 58–60 (1986).

    PubMed  Google Scholar 

  6. N. P. Stimler-Gerard,Parasympathetic stimulation is a mechanism for platelet-activating factor-induced contractile reponses in the lung, J. Pharmacol. Exp. Ther.237, 209–213 (1986).

    PubMed  Google Scholar 

  7. N. Tamura, D. K. Agrawal, F. A. Suliaman and R. G. Townley,Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects. Biochem. Biophys. Res. Commun.142, 638–644 (1987).

    Article  PubMed  Google Scholar 

  8. A. J. Wardlaw, R. Moqbel, O. Cromwell and A. B. Kay,Platelet activating factor. A potent chemotactic and chemokinetic factor for human eosinophils, J. Clin. Invest.78, 1701–1706 (1986).

    PubMed  Google Scholar 

  9. R. N. Pinckard, J. C. Ludwig and L. M. McManus,Plateletactivating factors, InInflammation: Basic principles and clinical correlates. (Eds. J. J. Gallin, I. M. Goldstein, R. Snyderman) Raven Press, New York, pp. 139–167 (1988).

    Google Scholar 

  10. N. Tamura, D. K. Agrawal and R. G. Townley,Leukotriene C 4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation. J. Immunol.141, 4291–4297 (1988).

    PubMed  Google Scholar 

  11. W. S. Adamus, H. Heuer, C. J. Meade and H. M. Brecht,Safety, tolerability, and pharmacologic activity of multiple doses of the new platelet activating factor antagonist WEB 2086 in human subjects. Clin. Pharmacol. Ther.45, 270–276 (1989).

    PubMed  Google Scholar 

  12. E. J. Dixon, P. Wilsoncroft, D. N. Robertson and C. P. Page,The effect of PAF antagonists on bronchial hyperresponsiveness induced by PAF, propranolol or indomethacin. Br. J. Pharmacol.97, 717–722 (1989).

    PubMed  Google Scholar 

  13. M. Soler, M. W. Sielczak and W. M. Abraham,A PAF antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep. J. Appl. Physiol.67, 406–413 (1989).

    PubMed  Google Scholar 

  14. B. Vargaftig,General pathophysiology of paf. Lung Respir.5, 2–3 (1988).

    Google Scholar 

  15. S. Wallenstein, C. L. Zucker and J. L. Fleiss,Some statistical methods useful in circulation research. Circ. Res.47, 1–9 (1980).

    PubMed  Google Scholar 

  16. H. M. Brecht,Effects and tolerability of WEB 2086 in healthy volunteers. Lung Respir.5, 8–10 (1988).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miyagawa, H., Nabe, M., Hopp, R.J. et al. The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils. Agents and Actions 37, 39–43 (1992). https://doi.org/10.1007/BF01987888

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01987888

Keywords

Navigation